These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 8804668)
21. Cholecystokinin satiety involves CCKA receptors perfused by the superior pancreaticoduodenal artery. Cox JE Am J Physiol; 1998 May; 274(5):R1390-6. PubMed ID: 9612407 [TBL] [Abstract][Full Text] [Related]
22. CCK is involved in both peripheral and central mechanisms controlling food intake in chickens. Rodríguez-Sinovas A; Fernández E; Manteca X; Fernández AG; Goñalons E Am J Physiol; 1997 Jan; 272(1 Pt 2):R334-40. PubMed ID: 9039026 [TBL] [Abstract][Full Text] [Related]
23. 2-Naphthalenesulphanyl-L-aspartyl-2-(phenethyl) amide (2-NAP) and food intake in rats: evidence that endogenous peripheral CCK does not play a major role as a satiety factor. Ebenezer IS; Baldwin BA Br J Pharmacol; 1995 Nov; 116(5):2371-4. PubMed ID: 8581271 [TBL] [Abstract][Full Text] [Related]
24. Centrally administered cholecystokinin suppresses feeding through a peripheral-type receptor mechanism. Crawley JN; Fiske SM; Durieux C; Derrien M; Roques BP J Pharmacol Exp Ther; 1991 Jun; 257(3):1076-80. PubMed ID: 2046021 [TBL] [Abstract][Full Text] [Related]
25. Intravenous cholecystokinin octapeptide in pigs reduces operant responding for food, water, sucrose solution or radiant heat. Baldwin BA; Cooper TR; Parrott RF Physiol Behav; 1983 Mar; 30(3):399-403. PubMed ID: 6306701 [TBL] [Abstract][Full Text] [Related]
26. Cholecystokinin- and dexfenfluramine-induced anorexia compared using devazepide and c-fos expression in the rat brain. Li BH; Rowland NE Regul Pept; 1994 Mar; 50(3):223-33. PubMed ID: 8016407 [TBL] [Abstract][Full Text] [Related]
27. The CCKA receptor antagonist devazepide inhibits the effect of apomorphine on vasopressin release in pigs. Parrott RF; Forsling ML Gen Pharmacol; 1994 Nov; 25(7):1337-40. PubMed ID: 7896043 [TBL] [Abstract][Full Text] [Related]
28. The CCKA receptor antagonist devazepide does not modify opioid self-administration or drug discrimination: comparison with the dopamine antagonist haloperidol. Higgins GA; Joharchi N; Wang Y; Corrigall WA; Sellers EM Brain Res; 1994 Mar; 640(1-2):246-54. PubMed ID: 8004452 [TBL] [Abstract][Full Text] [Related]
29. Cholecystokinin receptors do not mediate the behavioral effects of lipopolysaccharide in mice. Bluthé RM; Michaud B; Kelley KW; Dantzer R Physiol Behav; 1997 Aug; 62(2):385-9. PubMed ID: 9251984 [TBL] [Abstract][Full Text] [Related]
30. Effects of the novel cholecystokinin analogue Suc-Trp-N(Me)-Nle-Asp-Phe-NH2 on feeding and cortisol release in pigs. Ebenezer IS; Parrott RF; Goode JA Pharmacol Biochem Behav; 1996 May; 54(1):255-9. PubMed ID: 8728566 [TBL] [Abstract][Full Text] [Related]
31. Devazepide, a CCK(A) antagonist, attenuates the satiating but not the preference conditioning effects of intestinal carbohydrate infusions in rats. Pérez C; Lucas F; Sclafani A Pharmacol Biochem Behav; 1998 Feb; 59(2):451-7. PubMed ID: 9476995 [TBL] [Abstract][Full Text] [Related]
32. Effects of intracerebroventricular injection of dynorphin, leumorphin and alpha neo-endorphin on operant feeding in pigs. Baldwin BA; de la Riva C; Ebenezer IS Physiol Behav; 1990 Dec; 48(6):821-4. PubMed ID: 1982360 [TBL] [Abstract][Full Text] [Related]
33. Role of leptin in the control of feeding of goldfish Carassius auratus: interactions with cholecystokinin, neuropeptide Y and orexin A, and modulation by fasting. Volkoff H; Eykelbosh AJ; Peter RE Brain Res; 2003 May; 972(1-2):90-109. PubMed ID: 12711082 [TBL] [Abstract][Full Text] [Related]
34. Reciprocal interaction of 5-hydroxytryptamine and cholecystokinin in the control of feeding patterns in rats. Grignaschi G; Mantelli B; Fracasso C; Anelli M; Caccia S; Samanin R Br J Pharmacol; 1993 Jun; 109(2):491-4. PubMed ID: 8358548 [TBL] [Abstract][Full Text] [Related]
35. Cholecystokinin octapeptide inhibits carbohydrate but not protein intake. Mamoun AH; Bergström J; Södersten P Am J Physiol; 1997 Sep; 273(3 Pt 2):R972-80. PubMed ID: 9321876 [TBL] [Abstract][Full Text] [Related]
36. Effect of the CCKA antagonist devazepide on eating stimulated by raphe injection of 8-OH-DPAT. Currie PJ; Coscina DV Neuroreport; 1995 Dec; 7(1):253-6. PubMed ID: 8742464 [TBL] [Abstract][Full Text] [Related]
37. Age-dependent effects of CCK and devazepide in male and female rats. Salorio CF; Hammond PB; Schwartz GJ; McHugh PR; Moran TH Physiol Behav; 1994 Oct; 56(4):645-8. PubMed ID: 7800726 [TBL] [Abstract][Full Text] [Related]
38. Satiety induced by endogenous and exogenous cholecystokinin is mediated by CCK-A receptors in mice. Weatherford SC; Chiruzzo FY; Laughton WB Am J Physiol; 1992 Apr; 262(4 Pt 2):R574-8. PubMed ID: 1566921 [TBL] [Abstract][Full Text] [Related]
39. Evidence for an involvement of the brain cholecystokinin B receptor in anxiety. Singh L; Lewis AS; Field MJ; Hughes J; Woodruff GN Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1130-3. PubMed ID: 1996314 [TBL] [Abstract][Full Text] [Related]
40. Effect of L364.718 during suckling on the sensitivity to the hypophagic effect of cholecystokinin in adult rats. Voits M; Rödel S; Förster S; Plagemann A; Fink H Prog Neuropsychopharmacol Biol Psychiatry; 1997 Jan; 21(1):183-92. PubMed ID: 9075266 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]